Search Within

Paul Russo

  1. "Robert Motzer"
Formats
  1. Journal Article (83)
  2. Meeting Abstract (32)
  3. Book Section (1)
  4. Correspondence (1)
  5. Research Letter (1)
  6. Review (1)
Groups
  1. Department of Medicine (119)
  2. Genitourinary Oncology Service (119)
  3. Solid Tumor Oncology Division (119)
  4. Surgery (119)
  5. Urology (119)
  6. Department of Pathology and Laboratory Medicine (66)

More Groups

People
  1. Robert Motzer (119)
  2. Abraham Hakimi (59)
  3. Martin Voss (47)
  4. Victor Reuter (44)
  5. Jonathan Coleman (43)
  6. Yingbei Chen (23)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
  3. 2023 (8)
  4. 2022 (6)
  5. 2021 (11)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (27)
  2. Journal of Urology (11)
  3. BJU International (7)
  4. Cancer (6)
  5. Clinical Cancer Research (6)
  6. European Urology Focus (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (27)
  2. Elsevier Science, Inc. (20)
  3. Wiley Blackwell (14)
  4. Elsevier Inc. (11)
  5. American Association for Cancer Research (8)
  6. Springer (8)

More Publishers

Results (119)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitors
    Journal Article

    Khaleel, S.; Perera, M.; Papa, N.; Kuo, F.; Golkaram, M.; Rappold, P.; Kotecha, R. R.; Coleman, J.; Russo, P.; Motzer, R.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Adjuvant nivolumab for localized renal cell carcinoma at high risk of recurrence after nephrectomy: Part b of the randomized, placebo-controlled, phase III CheckMate 914 Trial
    Journal Article

    Motzer, R. J.; Bex, A.; Russo, P.; Tomita, Y.; Cutuli, H. J.; Rojas, C.; Gross-Goupil, M.; Schinzari, G.; Melichar, B.; Barthélémy, P.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Adjuvant nivolumab monotherapy vs placebo for localized renal cell carcinoma at high risk of relapse after nephrectomy: Results from Part B of the randomized, phase 3 CheckMate 914 trial
    Meeting Abstract

    Motzer, R. J.; Bex, A.; Russo, P.; Tomita, Y.; Cutuli, H.; Rojas, C.; Gross-Goupil, M.; Schinzari, G.; Melichar, B.; Barthelemy, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Comprehensive immunogenomic evaluation of patients undergoing consolidative cytoreductive nephrectomy in metastatic renal cell carcinoma patients treated with immune checkpoint blockade
    Meeting Abstract

    Reese, S.; Yarlagadda, V.; Wu, C. Y.; Kuo, F.; Tang, C.; Jiang, H.; Vuong, L. H.; Eismann, L.; Motzer, R.; Voss, M. H.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma
    Journal Article

    Reese, S. W.; Eismann, L.; White, C.; Arroyave Villada, J.; Khaleel, S.; Ostrovnaya, I.; Vazquez-Rivera, K.; Carlo, M. I.; Feldman, D.; Lee, C. H.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Localised non-metastatic sarcomatoid renal cell carcinoma: A 31-year externally verified study
    Journal Article

    Blum, K. A.; Silagy, A. W.; Knezevic, A.; Weng, S.; Wang, A.; Mano, R.; Marcon, J.; DiNatale, R. G.; Sanchez, A.; Tickoo, S.; more...
    BJU International (2024)

    Fulltext@MSK | Save
  • Functional and translational consequences of immunometabolic coevolution in ccRCC
    Meeting Abstract

    Reznik, E.; Tang, C.; Xie, A.; Liu, E. M.; Kuo, F.; Kim, M.; Golkaram, M.; Chen, Y.; Gupta, S.; Motzer, R.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Summary of research: Adjuvant nivolumab plus ipilimumab versus placebo for localized renal cell carcinoma after nephrectomy (CheckMate 914): A double-blind, randomized, phase 3 trial
    Journal Article

    Motzer, R. J.; Russo, P.; Grünwald, V.; Tomita, Y.; Zurawski, B.; Parikh, O.; Buti, S.; Barthélémy, P.; Goh, J. C.; Ye, D.; more...
    Targeted Oncology (2023)

    Fulltext@MSK | Save
  • Adjuvant nivolumab plus ipilimumab vs placebo for patients with localized renal cell carcinoma at high risk of relapse after nephrectomy: Subgroup analyses from the phase 3 CheckMate 914 (part A) trial
    Meeting Abstract

    Motzer, R. J.; Russo, P.; Grünwald, V.; Tomita, Y.; Barthélémy, P.; Goh, J. C.; Cutuli, H. J.; Simsek, B.; Spiridigliozzi, J.; Chudnovsky, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Immunometabolic coevolution defines unique microenvironmental niches in ccRCC
    Journal Article

    Tang, C.; Xie, A. X.; Liu, E. M.; Kuo, F.; Kim, M.; DiNatale, R. G.; Golkaram, M.; Chen, Y. B.; Gupta, S.; Motzer, R. J.; more...
    Cell Metabolism (2023)

    Fulltext@MSK | Save